Extracellular glutamate and IDH1R132H inhibitor promote glioma growth by boosting redox potential.
- Published in:
- Journal of Neuro-Oncology, 2020, v. 146, n. 3, p. 427, doi. 10.1007/s11060-019-03359-w
- By:
- Publication type:
- Article
Works matching IS 0167594X AND DT 2020 AND VI 146 AND IP 3
Results: 13
1
2
Objective assessment of intraoperative tumor fluorescence reveals biological heterogeneity within glioblastomas: a biometric study.
- Published in:
- Journal of Neuro-Oncology, 2020, v. 146, n. 3, p. 477, doi. 10.1007/s11060-019-03338-1
- By:
- Publication type:
- Article
3
KIF3C is associated with favorable prognosis in glioma patients and may be regulated by PI3K/AKT/mTOR pathway.
- Published in:
- Journal of Neuro-Oncology, 2020, v. 146, n. 3, p. 513, doi. 10.1007/s11060-020-03399-7
- By:
- Publication type:
- Article
4
Relationships between recurrence patterns and subventricular zone involvement or CD133 expression in glioblastoma.
- Published in:
- Journal of Neuro-Oncology, 2020, v. 146, n. 3, p. 489, doi. 10.1007/s11060-019-03381-y
- By:
- Publication type:
- Article
5
Contemporary management of pediatric spinal tumors: a single institute's experience in Taiwan in the modern era.
- Published in:
- Journal of Neuro-Oncology, 2020, v. 146, n. 3, p. 501, doi. 10.1007/s11060-020-03400-3
- By:
- Publication type:
- Article
6
Tumor treating fields plus temozolomide for newly diagnosed glioblastoma: a sub-group analysis of Korean patients in the EF-14 phase 3 trial.
- Published in:
- Journal of Neuro-Oncology, 2020, v. 146, n. 3, p. 399, doi. 10.1007/s11060-019-03361-2
- By:
- Publication type:
- Article
7
Rapamycin and hydroxychloroquine combination alters macrophage polarization and sensitizes glioblastoma to immune checkpoint inhibitors.
- Published in:
- Journal of Neuro-Oncology, 2020, v. 146, n. 3, p. 417, doi. 10.1007/s11060-019-03360-3
- By:
- Publication type:
- Article
8
The pretemporal trans-cavernous trans-Meckel's trans-tentorial trans-petrosal approach: a combo skill in treating skull base meningiomas.
- Published in:
- Journal of Neuro-Oncology, 2020, v. 146, n. 3, p. 407, doi. 10.1007/s11060-019-03354-1
- By:
- Publication type:
- Article
9
Editorial: advances in neuro-oncology and clinical treatment—from ASNO 2019.
- Published in:
- 2020
- By:
- Publication type:
- Editorial
10
Radiomics as prognostic factor in brain metastases treated with Gamma Knife radiosurgery.
- Published in:
- Journal of Neuro-Oncology, 2020, v. 146, n. 3, p. 439, doi. 10.1007/s11060-019-03343-4
- By:
- Publication type:
- Article
11
First-line bevacizumab contributes to survival improvement in glioblastoma patients complementary to temozolomide.
- Published in:
- Journal of Neuro-Oncology, 2020, v. 146, n. 3, p. 451, doi. 10.1007/s11060-019-03339-0
- By:
- Publication type:
- Article
12
l-asparaginase and 6-diazo-5-oxo-l-norleucine synergistically inhibit the growth of glioblastoma cells.
- Published in:
- Journal of Neuro-Oncology, 2020, v. 146, n. 3, p. 469, doi. 10.1007/s11060-019-03351-4
- By:
- Publication type:
- Article
13
The role of tailored intraoperative neurophysiological monitoring in glioma surgery: a single institute experience.
- Published in:
- Journal of Neuro-Oncology, 2020, v. 146, n. 3, p. 459, doi. 10.1007/s11060-019-03347-0
- By:
- Publication type:
- Article